CREATIVE BIOLABS
DEAD

Serial Number

87066979

Owner

Creative Biolabs, Inc.

Attorney

David Lin

First Use Date

Jan 1, 2006

Filing Date

Jun 10, 2016

Add to watchlist:

No watchlists yet
View on USPTO

CREATIVE BIOLABS Trademark

Serial Number: 87066979

CREATIVE BIOLABS is a trademark filed by Creative Biolabs, Inc. on June 10, 2016. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Creative Biolabs, Inc. (3 trademarks)

45-1 Ramsey Rd.
Shirley, NY 11967

Entity Type: 03

Trademark Details

Filing Date

June 10, 2016

Registration Date

Not Registered

First Use Anywhere

January 1, 2006

First Use in Commerce

January 1, 2006

Goods & Services

Bacteriological consultation and research; Bacteriological research; Bacteriological research and testing; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical analysis; Chemical engineering; Chemical laboratories; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Chemist services; Chemistry consultation; Compiling data for research purposes in the field of medical science and medical consultancy; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Custom design and development of chemical reagents and biochemical assays; Design and testing of new products for others; Design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; Development and test of chemical production methods; Development of pharmaceutical preparations and medicines; DNA analysis services for scientific research purposes; Drug discovery services; Executing of chemical analyses; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Laboratory analysis in the field of bacteriology, chemistry, and cosmetics; Laboratory research services relating to pharmaceuticals; Laboratory services, namely, pigment and color analysis; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research information in the field of drug discovery; Medical laboratory services; Medical research; Medical research services in the field of cancer; Performance of chemical analyses; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product testing; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Research and development in the field of drug discovery; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of technology in the field of drug discovery; Research in the field of chemistry; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of drug discovery, medicine, the prevention, treatment and management of illness, health care delivery, and cancerous diseases; Scientific research in the field of genetics and genetic engineering

Filing History

ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Mar 6, 2017 MAB1
ABANDONMENT - EXPRESS MAILED
Mar 6, 2017 ABN1
TEAS EXPRESS ABANDONMENT RECEIVED
Mar 3, 2017 EXAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 29, 2016 GNRN
NON-FINAL ACTION E-MAILED
Sep 29, 2016 GNRT
NON-FINAL ACTION WRITTEN
Sep 29, 2016 CNRT
ASSIGNED TO EXAMINER
Sep 21, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 18, 2016 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 17, 2016 NWOS
NEW APPLICATION ENTERED
Jun 14, 2016 NWAP